STOCK OPTIONS AND WARRANTS (Tables)

6 Months Ended

Jun. 30, 2024

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

SCHEDULE OF STOCK OPTIONS

	Shares			Price (1)		Term (2)
Outstanding, at December 31, 2023		127		$	62.45		3.4
Granted		105			-
Forfeited		(4	)		-
Exercised		-			-
Outstanding, at June 30, 2024		228	(3)		36.00		3.4
Exercisable, at June 30, 2024		121	(4)		57.35		3.1

(1)	Represents the weighted average exercise price.
(2)	Represents the weighted average remaining contractual term until the stock options expire.
(3)	As of June 30, 2024, the aggregate intrinsic value of stock options outstanding was $0.
(4)	As of June 30, 2024, the aggregate intrinsic value of exercisable stock options was $0.

SCHEDULE OF WARRANT OUTSTANDING

The following table sets forth activity with respect to the Company’s warrants to purchase Common Stock for the six months ended June 30, 2024 (shares in thousands):

	Shares			Price (1)		Term (2)
Outstanding, at December 31, 2023		2,821		$	13.15		4.6
Grants of warrants:
Private placement		6,271	(3)
Consultants for services		4	(4)
Warrant inducement		1,471	(5)
Exercised		(1,394	)(6)
Forfeited		(24	)
Outstanding, at June 30, 2024		9,149	(7)	$	2.96		4.5
Exercisable, at June 30, 2024		9,095	(8)	$	2.90		4.6

(1)	Represents the weighted average exercise price.
(2)	Represents the weighted average remaining contractual term until the warrants expire.
(3)	In June 30, 2024, the Company granted warrants in connection with a private placement consisting of warrants to purchase up to an aggregate of 3,220,266 shares of common stock at an exercise price of $2.204 per share, and pre-funded warrants to purchase up to an aggregate of 3,050,768 with a relative fair value of approximately $7.5 million which was recorded to additional paid-in capital at the time of issuance.
(4)	During the second quarter of 2024, the Company granted warrants to purchase up to an aggregate of 4,000 shares of common stock at an exercise price of $2.38 per share, to consultant for business development services.
(5)	In February 2024, the Company granted warrants in connection with a warrant inducement consisting of warrants to purchase up to an aggregate of 1,470,592 shares of common stock at an exercise price of $5.05 per share, with a relative fair value of approximately $3.9 million which was recorded to additional paid-in capital at the time of issuance.
(6)	During the first quarter of 2024, the Company issued an aggregate of 1,393,393 shares of common stock from the exercise of warrants previously issued in November 2023.
(7)	As of June 30, 2024, the aggregate intrinsic value of warrants outstanding was $0 million.
(8)	As of June 30, 2024, the aggregate intrinsic value of warrants exercisable was $0 million.

Warrant [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

SCHEDULE OF WEIGHTED AVERAGE ASSUMPTIONS USED IN THE FAIR VALUE

	2024
Measurement date closing price of Common Stock (1)	$	1.88
Contractual term (years) (2)		5.0
Risk-free interest rate		4.4	%
Volatility		140	%
Dividend yield		0	%

(1)	Weighted average grant price.
(2)	The valuation of warrants is based on the expected term.

Share-Based Payment Arrangement, Option [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

SCHEDULE OF WEIGHTED AVERAGE ASSUMPTIONS USED IN THE FAIR VALUE

	2024
Grant date closing price of Common Stock	$	2.38
Expected term (years)		3.5
Risk-free interest rate		4.3	%
Volatility		140	%
Dividend yield		0	%